Substance overview

Fenbendazole (FBZ)

Veterinary substance — not approved as human cancer therapy Fenbendazole is used against worms in animals. Formal large human cancer RCTs are essentially lacking. Lab findings are not the same as proven patient benefit. See also Pets.

Background

Fenbendazole belongs to the benzimidazoles (same family as mebendazole and albendazole). It gained attention via social media and patient forums. This page prioritizes peer-reviewed preclinical work and published case series. The FBZ debate is strong in Korea; lab studies also come from Korea and China — see World.

Preclinical findings

D Dogra et al., 2018 — microtubules, p53 & glucose

Fenbendazole acts as a moderate microtubule destabilizing agent… Scientific Reports. 2018.

DOI PubMed PMC
D Park et al., 2022 — 5-FU-resistant colorectal cancer

Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells.

PMC
D Duan et al., 2013 — null/negative breast model

Fenbendazole as a potential anticancer drug — EMT6 model without therapeutic value in that study.

PubMed
E Nguyen et al., 2024

Oral Fenbendazole for Cancer Therapy in Humans and Animals. Anticancer Research.

Journal

Case series (weaker evidence)

C Makis et al. — self-administration case series

Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration…

PMC

Veterinary context & pets

FBZ (Panacur/Axilur etc.) is intended for animals. Sweden uses selective/risk-based deworming (fecal tests, not blind routine) — while shared runs raise infection pressure. Chain continues: sick animals → caregiver burden on owners. Resistance is serious in horses/sheep and MDR hookworm in the US, but Toxocara still responds to fenbendazole in Swedish/European assessment. See Pets, processes, sources.

Observations of tumor shrinkage in pets may interest veterinary oncology but do not automatically transfer to humans.

What major organizations say

American Cancer Society

What to Know About Fenbendazole

cancer.org

Bottom line FBZ × cancer Published preclinical signals (microtubules, resistant lines) are worth following. Human evidence is thin; social media and case series dominate debate. Closest “human-approved sibling” is mebendazole — see that page for formal phase I/II data.

Compare mebendazole Pets Sources